Below are the most recent publications written about "T-Lymphocytes" by people in Profiles.
-
Steinbuck MP, Seenappa LM, Zhan W, Palmer E, Jung MM, Jakubowski A, Cabana-Puig X, McNeil LK, Haqq CM, Fitzgerald KA, DeMuth PC. Lymph node-targeted DNA engages TBK1/IFN-I-driven innate immunity to induce potent T cell responses and durable memory in mice and NHPs. Sci Adv. 2026 May 29; 12(22):eaec1416.
-
Hamadeh IS, Merz M, Derkach A, Modelevsky L, Lesokhin AM, Mailankody S, Hultcrantz ML, Tan CR, Hassoun H, Shah UA, Maclachlan K, Rajeeve S, Hashmi H, Maura F, Firestone RS, Wang AX, Amin A, Patel D, Scordo M, Shah GL, Landau HJ, Giralt S, Usmani SZ, Korde N. Low Dose Tocilizumab for Mitigation of Cytokine Release Syndrome With T-Cell Engaging Bispecific Antibodies. Clin Lymphoma Myeloma Leuk. 2026 Jun; 26(6):e802-e810.
-
Koumpouras F, Caricchio R. Cellular therapies for rheumatic disease. Curr Opin Rheumatol. 2026 May 01; 38(3):155-162.
-
Wang Z, Amenyogbe N, Ben-Othman R, Cai B, Lo M, Idoko OT, Odumade OA, Falsafi R, Blimkie TM, An A, Shannon CP, Montante S, Dhillon BK, Diray-Arce J, Ozonoff A, Smolen KK, Brinkman RR, McEnaney K, Angelidou A, Richmond P, Tebbutt SJ, Kampmann B, Hancock REW, Lee AHY, Levy O, Kollmann TR, Martino D. Higher Promoter Methylation of the Ubiquitin-Associated and SH3 Domain Containing A (UBASH3A) Gene Is Associated With T-Lymphocyte Ontogeny and Reduced Susceptibility to Early-Onset Sepsis. J Infect Dis. 2026 Mar 17; 233(3):e706-e711.
-
Amdare N, Ali R, Manganaro A, Baker JC, Antal Z, Smith C, Santamaria P, Kent SC, DiLorenzo TP. Islet-derived T cells from both mice and humans recognize conserved insulin A-chain peptides presented by HLA-C*03:04. J Immunol. 2026 02 09; 215(2).
-
Gaglione SA, Mukkamala RS, Krishna C, Smith BE, Wadsworth MH, Jelinsky SA, Perez CR, Schmidt-Hong L, Katz EL, Gellatly KJ, Ali LR, Shen J, Holec PV, Zhao QH, Chan AO, Xu EJK, Kravarik KM, Guzova JA, Dobson CS, Singh H, Garber M, Dougan M, Dougan SK, Harris JE, Winkler A, Birnbaum ME. Scalable TCR synthesis and screening enable antigen reactivity mapping in vitiligo. Immunity. 2026 Feb 10; 59(2):477-493.e9.
-
Itoh-Nakadai A, Liang M, Shindo M, Bibi C, Tomizawa-Murasawa M, Fujiki S, Kaneko A, Kanamaru E, Hashimoto M, Kajita H, Ando Y, Kojima M, Moody J, Iwasaki M, Takagi S, Nakagawa R, Agrawal S, Amitani-Iijima H, Sato K, Sorimachi Y, Suzuki N, Fukami T, Hanada K, Morita S, Katsura K, Matsumoto T, Kobayashi M, Kato M, Negishi Y, Shirouzu M, Najima Y, Takubo K, Hon CC, Uchida N, Taniguchi S, Momozawa Y, Carninci P, Shultz LD, Saito Y, de Hoon M, Shin JW, Ishikawa F. CXCR4 induces memory formation over exhaustion in CAR-T cells to achieve durable leukemia targeting. Nat Commun. 2026 Jan 26; 17(1):101.
-
Neff HA, Yildiz-Altay ?, Salam N, Ward DV, Shepard D, Ramirez-Ortiz ZG, Richmond JM. Gut dysbiosis in a murine model of cutaneous lupus erythematosus correlates with antigen-specific T cells and antigen-presenting cells in skin. Sci Rep. 2026 Jan 12; 16(1):4511.
-
Ramesh KM, Lu L, Stern LJ. T Cell Assay to Track Presentation of an Influenza Hemagglutinin Epitope Presented by the MHC-II Protein HLA-DR1. Methods Mol Biol. 2026; 3007:255-273.
-
Mortensen R, Arlehamn CSL, Coler RN, Gerner MY, Goletti D, Lewinsohn DA, Modlin RL, Musvosvi M, Rengarajan J, Urdahl KB, Walzl G, Behar SM, Barber DL. T cell-macrophage interactions in tuberculosis: What we've got here is failure to communicate. J Intern Med. 2026 Jan; 299(1):44-65.